Physician profile
Benjamin Tripp
NPI 1083702997
$2,283.99
in general payments reported to CMS, 2019-2025
22 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $16.04 · 2021: $1,163 · 2022: $422 · 2023: $29.98 · 2024: $173 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397 · Education: $78.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.09 |
| Education | $78.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $1,129.33 | 2021-2022 | |
| Procept Biorobotics Corporation | $267.55 | 2022-2025 | |
| Abbvie INC. | $131.83 | 2019-2024 | |
| Medtronic, INC. | $116.21 | 2022-2025 | Interstim |
| Astellas Pharma US INC | $101.53 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $79.76 | 2019-2022 | |
| Boston Scientific Corporation | $59.84 | 2022-2024 | Rezum Generator |
| Coloplast Corp | $53.64 | 2021-2024 | Speedicath |
| Antares Pharma, INC. | $43.78 | 2022 | |
| Astellas Pharma Global Development | $43.75 | 2024 | Xtandi |
| Janssen Biotech, INC. | $39.29 | 2024 | Erleada |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Pfizer INC. | $33.76 | 2021-2025 | |
| Neotract INC. | $21.07 | 2019 | |
| Myovant Sciences INC. | $19.05 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agiliti Surgical, INC. | $16.92 | 2022 | |
| Laborie Medical Technologies Corp. | $16.35 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Verity Pharmaceuticals INC. | $16.10 | 2022 | |
| Endo Pharmaceuticals INC. | $16.04 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.37 | 2023 | |
| Teleflex LLC | $15.21 | 2024 | Urolift |
| Dusa Pharmaceuticals, INC. | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Tripp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.